Loading…
CIK 0001822947 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ally-bridge-group-ny-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS INC | COM | $5.9M | 3.6% | 437,391 SH | New |
| ARCUTIS BIOTHERAPEUTICS INC | COM | $4.4M | 2.7% | 233,220 SH | New |
| ASCENDIS PHARMA A/S - ADR | SPONSORED ADR | $10.2M | 6.2% | 51,080 SH | New |
| ATAI BECKLEY NV | SHS | $12.1M | 7.4% | 2,287,005 SH | New |
| ATYR PHARMA INC | COM NEW | $433K | 0.3% | 600,000 SH | New |
| AVALO THERAPEUTICS INC | COM NEW | $2.3M | 1.4% | 178,100 SH | New |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $12.4M | 7.6% | 2,172,082 SH | New |
| EUPRAXIA PHARMACEUTICALS INC | COM | $5.4M | 3.3%Prev: 1.5% | 915,000 SH | Increased+662,825 SH |
| LENZ THERAPEUTICS INC | COM | $8.2M | 5.0% | 175,363 SH | New |
| MADRIGAL PHARMACEUTICALS INC | COM | $15.0M | 9.1% | 32,662 SH | New |
| MIND MEDICINE MINDMED INC | COM NEW | $4.3M | 2.6% | 361,444 SH | New |
| MONOPAR THERAPEUTICS INC | COM NEW | $5.3M | 3.2% | 64,455 SH | New |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $495K | 0.3% | 69,000 SH | New |
| PRAXIS PRECISION MEDICINES I | COM NEW | $5.3M | 3.2% | 100,000 SH | New |
| PROMIS NEUROSCIENCES INC | COM NEW | $2.6M | 1.6% | 6,233,497 SH | New |
| REPLIMUNE GROUP INC | COM | $15.1M | 9.2% | 3,600,000 SH | New |
| SOLENO THERAPEUTICS INC | COM | $37.3M | 22.7% | 552,483 SH | New |
| SOLID BIOSCIENCES INC | COM NEW | $3.4M | 2.1% | 549,182 SH | New |
| TARSUS PHARMACEUTICALS INC | COM | $4.2M | 2.6% | 70,778 SH | New |
| TAYSHA GENE THERAPIES INC | COM SHS | $6.2M | 3.8% | 1,898,112 SH | New |
| TECTONIC THERAPEUTIC INC | COM | $2.2M | 1.3% | 138,595 SH | New |
| WHITEHAWK THERAPEUTICS INC | COM | $1.6M | 0.9%Prev: 3.3% | 817,939 SH | Decreased |
| 13F-HR |
| 0001193125-26-352338 |
| $113.1M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000950123-25-008419 | $120.2M | View |
| May 18, 2026 | Q1 2026 | 13F-HR | 0001193125-26-227559 | $123.8M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000950123-25-005586 | $110.9M | View |